Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein

被引:36
|
作者
Marbeuf-Gueye, C
Ettori, D
Priebe, W
Kozlowski, H
Garnier-Suillerot, A
机构
[1] Univ Paris 13, UPRES A7033, Lab Physicochim Biomol & Cellulaire, F-93017 Bobigny, France
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Wroclaw B Beirut Univ, Inst Chem, PL-50383 Wroclaw, Poland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1999年 / 1450卷 / 03期
关键词
multidrug resistance; P-glycoprotein; MRP; doxorubicin; kinetic; resistance factor;
D O I
10.1016/S0167-4889(99)00060-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multidrug resistance (MDR) in model systems is known to be conferred by two different integral proteins, the 170-kDa P-glycoprotein (Pgp) and the 190-kDa multidrug resistance associated protein (MRP1). One possible pharmacological approach to overcome drug resistance is the use of specific inhibitors, which enhance the cytotoxicity of known antineoplastic agents. However, while many compounds have been proven to be very efficient in inhibiting Pgp activity only some of them are able to inhibit MRP1. The other Likely approach is based on the design and synthesis of new non-cross-resistant drugs with physicochemical properties favoring the uptake of the drug by the resistant cells. The intracellular drug retention influences its cytotoxic effect. The level of the intracellular drug content is a function of the amount of drug transported inside the cell (influx) and the amount of drug expelled from the cell (efflux). In this work, the kinetics of drug uptake and the kinetics of active efflux of several anthracycline derivatives in both Pgp expressing K562/Adr cells and MRP1 expressing GLC4/Adr cells was determined. Our data have shown that in both cell lines there is no correlation between the resistance Factor and the kinetics of drug efflux by these pumping systems. However, a very good correlation between the resistance factor and the kinetics of drug uptake has been established in both cell lines: the resistance factor decreases when the kinetics of drug uptake increases; This work has clearly shown that when the rate of transmembrane transport of anthracycline is high enough, the efflux mediated by the protein transporter is not able to pace with it. The protein transporter essentially operates in a futile cycle and the resistance factor is tending to one. It does not mean, however, that when the resistance factor is close to one the anthracycline is not transported by the pump. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 50 条
  • [41] MULTIDRUG-RESISTANCE MEDIATED BY P-GLYCOPROTEIN IN HEMATOLOGICAL MALIGNANCIES
    PASMAN, PC
    SCHOUTEN, HC
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 42 (5-6) : 218 - 231
  • [42] P-glycoprotein mediated multidrug resistance and its implications for pathology
    Trambas, CM
    Muller, HK
    Woods, GM
    PATHOLOGY, 1997, 29 (02) : 122 - 130
  • [43] MULTIDRUG-RESISTANCE AND THE ROLE OF P-GLYCOPROTEIN KNOCKOUT MICE
    SCHINKEL, AH
    MOL, CAAM
    WAGENAAR, E
    VANDEEMTER, L
    SMIT, JJM
    BORST, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) : 1295 - 1298
  • [44] STAUROSPORINE REDUCES P-GLYCOPROTEIN EXPRESSION AND MODULATES MULTIDRUG RESISTANCE
    SAMPSON, KE
    WOLF, CL
    ABRAHAM, I
    CANCER LETTERS, 1993, 68 (01) : 7 - 14
  • [45] USING PURIFIED P-GLYCOPROTEIN TO UNDERSTAND MULTIDRUG-RESISTANCE
    SHAPIRO, AB
    LING, V
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) : 7 - 13
  • [46] A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance
    Andrivon, W
    Monneret, C
    Nafziger, J
    Florent, JC
    Guillosson, JJ
    LEUKEMIA RESEARCH, 1998, 22 (08) : 719 - 725
  • [47] In silico identified targeted inhibitors of P-glycoprotein overcome multidrug resistance in human cancer cells in culture
    Follit, Courtney A.
    Brewer, Frances K.
    Wise, John G.
    Vogel, Pia D.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (05):
  • [48] Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression
    vanTriest, B
    Pinedo, HM
    Telleman, F
    vanderWilt, CL
    Jansen, G
    Peters, GJ
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (12) : 1855 - 1866
  • [49] Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1
    Nabekura, Tomohiro
    Yamaki, Takeshi
    Kitagawa, Shuji
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) : 45 - 49
  • [50] Inhibition of P-Glycoprotein Mediated Multidrug Resistance by Stemofoline Derivatives
    Umsumarng, Sonthaya
    Pintha, Komsak
    Pitchakarn, Pornsiri
    Sastraruji, Kwankamol
    Sastraruji, Thanapat
    Ung, Alison T.
    Jatisatienr, Araya
    Pyne, Stephen G.
    Limtrakul, Pornngarm
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (04) : 399 - 404